| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.21B | +5.4% |
| Cost of Revenue | $1.73B | +6.6% |
| R&D Expense | $513.6M | +9.1% |
| SG&A Expense | $656.7M | +5.6% |
| Operating Income | $566.9M | +6.3% |
| Interest Expense | $30.8M | +13.4% |
| Pre-tax Income | $602.4M | +2.6% |
| Income Tax | $150.4M | +83.2% |
| Net Income | $452.0M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $930.2M | +79.7% |
| Short-term Investments | $256.3M | -76.2% |
| Accounts Receivable | $793.7M | +9.1% |
| Current Assets | $2.29B | -11.3% |
| Total Assets | $11.48B | +10.7% |
| Current Liabilities | $967.5M | -53.7% |
| Total Liabilities | $6.50B | +18.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.52B | -0.0% |
| Capital Expenditures | $507.8M | +30.1% |
| Investing Cash Flow | -$540.7M | +32.3% |
| Financing Cash Flow | -$588.0M | +13.5% |
| Free Cash Flow | $1.01B | -10.4% |
| -10.5% |
| EPS (Basic) | $3.11 | -6.9% |
| EPS (Diluted) | $3.07 | -6.1% |
| Stockholders' Equity |
| $4.98B |
| +2.0% |